Assetmark Inc. Has $1.24 Million Stock Position in Sabra Healthcare REIT, Inc. $SBRA

Assetmark Inc. increased its position in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 70.2% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 66,736 shares of the real estate investment trust’s stock after buying an additional 27,520 shares during the period. Assetmark Inc.’s holdings in Sabra Healthcare REIT were worth $1,244,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Wedbush Securities Inc. boosted its holdings in Sabra Healthcare REIT by 18.3% in the third quarter. Wedbush Securities Inc. now owns 14,612 shares of the real estate investment trust’s stock worth $272,000 after acquiring an additional 2,259 shares in the last quarter. MQS Management LLC acquired a new position in shares of Sabra Healthcare REIT during the third quarter worth approximately $549,000. Oppenheimer & Co. Inc. raised its position in shares of Sabra Healthcare REIT by 1.7% during the third quarter. Oppenheimer & Co. Inc. now owns 33,984 shares of the real estate investment trust’s stock worth $633,000 after purchasing an additional 581 shares during the period. Waterloo Capital L.P. lifted its holdings in shares of Sabra Healthcare REIT by 2.6% in the 3rd quarter. Waterloo Capital L.P. now owns 261,598 shares of the real estate investment trust’s stock worth $4,876,000 after purchasing an additional 6,668 shares in the last quarter. Finally, Hantz Financial Services Inc. grew its position in Sabra Healthcare REIT by 209.1% in the 3rd quarter. Hantz Financial Services Inc. now owns 3,956 shares of the real estate investment trust’s stock valued at $74,000 after purchasing an additional 2,676 shares during the period. 99.40% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

SBRA has been the topic of several research reports. Wall Street Zen downgraded shares of Sabra Healthcare REIT from a “hold” rating to a “sell” rating in a report on Friday, January 23rd. Citizens Jmp boosted their price objective on Sabra Healthcare REIT from $22.00 to $23.00 and gave the stock a “market outperform” rating in a report on Wednesday. Citigroup increased their price objective on Sabra Healthcare REIT from $21.00 to $24.00 and gave the stock a “buy” rating in a research note on Wednesday. Cantor Fitzgerald upped their price target on Sabra Healthcare REIT from $20.00 to $21.00 and gave the stock a “neutral” rating in a report on Tuesday. Finally, Jefferies Financial Group reissued a “buy” rating and issued a $22.00 price target on shares of Sabra Healthcare REIT in a research report on Monday, December 15th. Five analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company. According to data from MarketBeat.com, Sabra Healthcare REIT has a consensus rating of “Moderate Buy” and a consensus price target of $21.70.

Sabra Healthcare REIT Stock Down 0.0%

Sabra Healthcare REIT stock opened at $20.02 on Friday. The company has a quick ratio of 4.29, a current ratio of 4.29 and a debt-to-equity ratio of 0.90. The company has a market capitalization of $5.05 billion, a P/E ratio of 31.28, a P/E/G ratio of 1.61 and a beta of 0.67. The firm has a 50 day moving average price of $19.13 and a 200-day moving average price of $18.82. Sabra Healthcare REIT, Inc. has a twelve month low of $15.60 and a twelve month high of $20.70.

Sabra Healthcare REIT (NASDAQ:SBRA) last posted its quarterly earnings data on Thursday, February 12th. The real estate investment trust reported $0.11 EPS for the quarter, missing the consensus estimate of $0.37 by ($0.26). Sabra Healthcare REIT had a net margin of 20.09% and a return on equity of 5.63%. The firm had revenue of $201.35 million during the quarter, compared to analysts’ expectations of $201.97 million. During the same quarter in the previous year, the company posted $0.36 EPS. Sabra Healthcare REIT’s revenue for the quarter was up 16.2% on a year-over-year basis. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. As a group, equities analysts predict that Sabra Healthcare REIT, Inc. will post 1.45 EPS for the current year.

Sabra Healthcare REIT Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 27th. Investors of record on Friday, February 13th will be issued a $0.30 dividend. The ex-dividend date of this dividend is Friday, February 13th. This represents a $1.20 annualized dividend and a yield of 6.0%. Sabra Healthcare REIT’s dividend payout ratio (DPR) is 187.50%.

Sabra Healthcare REIT Company Profile

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.